Mirae Asset Global ETFs Holdings
ITOS

Mirae Asset Global ETFs Holdings’s iTeos Therapeutics ITOS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,351
Closed -$163K – 3122
2025
Q2 		$163K Buy
16,351
+371
+2% +$2.99K ﹤0.01% 2383
2025
Q1 		$95.4K Buy
15,980
+702
+5% +$5.15K ﹤0.01% 2653
2024
Q4 		$117K Sell
15,278
-989
-6% -$8.5K ﹤0.01% 2637
2024
Q3 		$167K Buy
16,267
+1,896
+13% +$28.9K ﹤0.01% 2467
2024
Q2 		$214K Buy
+14,371
New +$206K ﹤0.01% 2213

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ITOS Position: Q3 2025 in Review

Mirae Asset Global ETFs Holdings sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 16,351 shares — an estimated $163K sold.

Mirae Asset Global ETFs Holdings first reported a position in ITOS in Q2 2024 and held it in 5 quarters. The position peaked at $214K in Q2 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 16,351 iTeos Therapeutics shares in Q3 2025, an estimated $163K.
  • Mirae Asset Global ETFs Holdings first reported a position in iTeos Therapeutics in Q2 2024 and held it in 5 quarters.
  • Mirae Asset Global ETFs Holdings's iTeos Therapeutics position peaked at $214K in Q2 2024.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.